Could Plasmalogen Treatment Results for RCDP* Signal Hope for Alzheimer’s Sufferers? Fifteen years of neuroscientific research led Dr Dayan Goodenowe to a landmark discovery – a single molecule much lower than normal in the blood of people with Alzheimer’s Disease. Using his own technology, he identified that molecule as plasmalogen – an essential brain nutrient found in mother’s breast milk. Was Alzheimer’s being caused by its depletion in brain cells? What would happen if it could be restored? The challenge was set. Since 2007, Goodenowe has researched and developed a treatment now being trialed by hundreds of doctors across America on Alzheimer’s sufferers. But on the opposite end of the life spectrum, two children with a rare (1 in every 100,000 births) disease – RCDP* – are rapidly and profoundly displaying this treatment’s effects. Witness the changes in the two children, which signal hope not just for their diagnosis, but for treating other serious diseases, including Alzheimer’s—on #Vitalsigns with Brendon Fallon. You can find out more about Dr. Dayan Goodenowe’s research at: https://drgoodenowe.com/ #dayangoodenowe #sheldonjordan #rcdp #alzheimers #dementia *RCDP - rhizomelic chondrodysplasia punctata ----------------------------------------------------------------------------------------------------------------------------------------- Related research by Dr Goodenowe: Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia https://www.jlr.org/article/S0022-2275(20)42448-4/fulltext Relation of Serum Plasmalogens and APOE Genotype to Cognition and Dementia in Older Persons in a Cross-Sectional Study https://www.mdpi.com/2076-3425/9/4/92 Plasmalogen deficiency and neuropathology in Alzheimer’s disease: Causation or coincidence? https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1016/j.trci.2019.08.003 Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species https://www.frontiersin.org/articles/10.3389/fcell.2022.866156/full Targeted Plasmalogen Supplementation: Effects on Blood Plasmalogens, Oxidative Stress Biomarkers, Cognition, and Mobility in Cognitively Impaired Persons https://www.frontiersin.org/articles/10.3389/fcell.2022.864842/full =================================================================================== Vital Signs’ host, guests and contributors offer general information on improving health and wellness. This is not intended as diagnosis or medical advice. You should consult your medical doctor or holistic doctor before enacting any suggested strategies for health and wellness improvement, including those in relation to preventing or treating specific diseases featured on this program.